The Vaccine Book, Second Edition provides comprehensive information on the current and future state of vaccines. It reveals the scientific opportunities and potential impact of vaccines, including economic and ethical challenges, problems encountered when producing vaccines, how clinical vaccine trials are designed, and how to introduce vaccines into widespread use. Although vaccines are now available for many diseases, there are still challenges ahead for major diseases, such as AIDS, tuberculosis, and malaria. This book is designed for students, researchers, public health officials, and all others interested in increasing their understanding of vaccines. It answers common questions regarding the use of vaccines in the context of a rapidly expanding anti-vaccine environment. This new edition is completely updated and revised with new and unique topics, including new vaccines, problems of declining immunization rates, trust in vaccines, the vaccine hesitancy, and the social value of vaccines for the community vs. the individual child's risk.

In 2009, to mark the sixtieth anniversary of the People's Republic of China, the Fairbank Center for Chinese Studies convened a major conference to discuss the health and longevity of China's ruling system and to consider a fundamental question: After three decades of internal strife and turmoil, followed by an era of reform, entrepreneurialism, and internationalization, is the PRC here for the dynastic long haul?

Bringing together scholars and students of China from around the world, the gathering witnessed an energetic exchange of views on four interrelated themes: polities, social transformations, wealth and well-being, and culture, belief, and practice. Edited and expanded from the original conference papers, the wide-ranging essays in this bilingual volume remain true to the conference's aim: to promote open discussion of the past, present, and future of the People's Republic of China.

Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasises the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings.